Literature DB >> 18599641

The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

Victor A Streltsov1, Stephen J Titmuss, V Chandana Epa, Kevin J Barnham, Colin L Masters, Joseph N Varghese.   

Abstract

Neurodegeneration observed in Alzheimer disease (AD) is believed to be related to the toxicity from reactive oxygen species (ROS) produced in the brain by the amyloid-beta (Abeta) protein bound primarily to copper ions. The evidence for an oxidative stress role of Abeta-Cu redox chemistry is still incomplete. Details of the copper binding site in Abeta may be critical to the etiology of AD. Here we present the structure determined by combining x-ray absorption spectroscopy (XAS) and density functional theory analysis of Abeta peptides complexed with Cu(2+) in solution under a range of buffer conditions. Phosphate-buffered saline buffer salt (NaCl) concentration does not affect the high-affinity copper binding mode but alters the second coordination sphere. The XAS spectra for truncated and full-length Abeta-Cu(2+) peptides are similar. The novel distorted six-coordinated (3N3O) geometry around copper in the Abeta-Cu(2+) complexes include three histidines: glutamic, or/and aspartic acid, and axial water. The structure of the high-affinity Cu(2+) binding site is consistent with the hypothesis that the redox activity of the metal ion bound to Abeta can lead to the formation of dityrosine-linked dimers found in AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599641      PMCID: PMC2547438          DOI: 10.1529/biophysj.108.134429

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  52 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

2.  Estimation of uncertainties in XAFS data.

Authors:  M Newville; B I Boyanov; D E Sayers
Journal:  J Synchrotron Radiat       Date:  1999-05-01       Impact factor: 2.616

3.  Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Authors:  Luc Guilloreau; Luminita Damian; Yannick Coppel; Honoré Mazarguil; Mathias Winterhalter; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2006-08-22       Impact factor: 3.358

4.  Different hydration changes accompanying copper and zinc binding to amyloid beta-peptide: water contribution to metal binding.

Authors:  Haijia Yu; Jinsong Ren; Xiaogang Qu
Journal:  Chembiochem       Date:  2008-04-14       Impact factor: 3.164

5.  Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.

Authors:  Anna K Tickler; Danielle G Smith; Giuseppe D Ciccotosto; Deborah J Tew; Cyril C Curtain; Darryl Carrington; Colin L Masters; Ashley I Bush; Robert A Cherny; Roberto Cappai; John D Wade; Kevin J Barnham
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

6.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

7.  NMR studies of the Zn2+ interactions with rat and human beta-amyloid (1-28) peptides in water-micelle environment.

Authors:  Elena Gaggelli; Anna Janicka-Klos; Elzbieta Jankowska; Henryk Kozlowski; Caterina Migliorini; Elena Molteni; Daniela Valensin; Gianni Valensin; Ewa Wieczerzak
Journal:  J Phys Chem B       Date:  2007-12-12       Impact factor: 2.991

Review 8.  X-ray absorption and diffraction studies of the metal binding sites in amyloid beta-peptide.

Authors:  Victor Streltsov
Journal:  Eur Biophys J       Date:  2007-11-15       Impact factor: 1.733

9.  Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides.

Authors:  Velia Minicozzi; Francesco Stellato; Massimiliano Comai; Mauro Dalla Serra; Cristina Potrich; Wolfram Meyer-Klaucke; Silvia Morante
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  23 in total

1.  Structural studies of copper(I) complexes of amyloid-beta peptide fragments: formation of two-coordinate bis(histidine) complexes.

Authors:  Richard A Himes; Ga Young Park; Gnana Sutha Siluvai; Ninian J Blackburn; Kenneth D Karlin
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

2.  Generation of soluble oligomeric beta-amyloid species via copper catalyzed oxidation with implications for Alzheimer's disease: a DFT study.

Authors:  Fredrik Haeffner; Kevin J Barnham; Ashley I Bush; Tore Brinck
Journal:  J Mol Model       Date:  2009-11-20       Impact factor: 1.810

3.  Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide.

Authors:  Zhengjian Lv; Margaret M Condron; David B Teplow; Yuri L Lyubchenko
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-11       Impact factor: 4.147

4.  Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease.

Authors:  Xueli Zhang; Yanli Tian; Zeng Li; Xiaoyu Tian; Hongbin Sun; Hong Liu; Anna Moore; Chongzhao Ran
Journal:  J Am Chem Soc       Date:  2013-10-25       Impact factor: 15.419

5.  Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer's disease that exhibit neurodegeneration.

Authors:  Megan W Bourassa; Andreana C Leskovjan; Ryan V Tappero; Erik R Farquhar; Carol A Colton; William E Van Nostrand; Lisa M Miller
Journal:  Biomed Spectrosc Imaging       Date:  2013-04-01

Review 6.  Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.

Authors:  Xian-Le Bu; Praveen P N Rao; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2015-06-23       Impact factor: 5.590

Review 7.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

8.  Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-beta complexes.

Authors:  Christelle Hureau; Véronique Balland; Yannick Coppel; Pier Lorenzo Solari; Emiliano Fonda; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2009-07-18       Impact factor: 3.358

9.  The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.

Authors:  Jason Shearer; Veronika A Szalai
Journal:  J Am Chem Soc       Date:  2008-12-31       Impact factor: 15.419

10.  Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.

Authors:  Xiayoue Zhu; Tiffany W Victor; Ashwin Ambi; Joseph K Sullivan; Joshua Hatfield; Feng Xu; Lisa M Miller; William E Van Nostrand
Journal:  Metallomics       Date:  2020-02-27       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.